BREAKING
MAJOR82
APPROVALLimited grounding
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic® - PR Newswire
Apotex, a Canadian drugmaker, got approval from Health Canada to sell a generic copy of Ozempic (semaglutide), a popular weight-loss and diabetes medicine. This is the first generic version approved by Canada's health regulator.
Analysis
First Health Canada generic semaglutide approval breaches Novo's Ozempic franchise in a major market, foreshadowing global IP erosion as semaglutide patents face challenges.
- Apotex received Health Canada approval for a generic equivalent of Ozempic (semaglutide)
- First Canadian-based pharma company to win generic Ozempic approval in Canada
Semaglutide News2d
Read